Wendy Stock to Genetic Testing
This is a "connection" page, showing publications Wendy Stock has written about Genetic Testing.
Connection Strength
0.373
-
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012). Breast Cancer Res Treat. 2010 Jan; 119(2):391-8.
Score: 0.260
-
Management of acute lymphoblastic leukemia in young adults. Clin Adv Hematol Oncol. 2018 Feb; 16(2):138-146.
Score: 0.114